These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11377519)

  • 1. New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics.
    Barten MJ; van Gelder T; Gummert JF; Shorthouse R; Boeke K; Billingham ME; Morris RE
    Transplant Proc; 2001 May; 33(3):2254-5. PubMed ID: 11377519
    [No Abstract]   [Full Text] [Related]  

  • 2. Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.
    Klupp J; van Gelder T; Dambrin C; Regieli J; Boeke K; Billingham ME; Morris RE
    Transplant Proc; 2001 May; 33(3):2170-1. PubMed ID: 11377490
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays.
    Barten MJ; Gummert JF; van Gelder T; Shorthouse R; Morris RE
    Transplant Proc; 2001 May; 33(3):2119-20. PubMed ID: 11377470
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil.
    Barten MJ; Rahmel A; Richter M; Tarnok A; Bartsch P; Boeger M; Gehlhaar P; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2002 Sep; 34(6):2372-3. PubMed ID: 12270442
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection.
    Barten MJ; van Gelder T; Gummert JF; Boeke K; Shorthouse R; Billingham ME; Morris RE
    Am J Transplant; 2002 Sep; 2(8):719-32. PubMed ID: 12243493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
    Klupp J; van Gelder T; Dambrin C; Regieli JJ; Boeke K; Billingham ME; Morris RE
    J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor treatment with mycophenolate mofetil protects against ischemia-reperfusion injury.
    Paul LC; Valentin JF; Bruijn JA; Zhang S
    Transplant Proc; 1999; 31(1-2):1026. PubMed ID: 10083456
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of major histocompatibility disparity on mycophenolate mofetil immunosuppression in rat pancreas transplantation.
    Schulak JA; Krishnamurthi V; Masih R; Robinson A
    Transplant Proc; 1995 Dec; 27(6):3010-1. PubMed ID: 8539816
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785).
    Hullett DA; Kawamura T; Fujino Y; Allison AM; Sollinger HW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):700-1. PubMed ID: 8438444
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolate mofetil interferes with interferon gamma production in T-cell activation models.
    Izeradjene K; Quemeneur L; Michallet MC; Bonnefoy-Berard N; Revillard JP
    Transplant Proc; 2001 May; 33(3):2110-1. PubMed ID: 11377468
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.
    Morris RE; Wang J; Blum JR; Flavin T; Murphy MP; Almquist SJ; Chu N; Tam YL; Kaloostian M; Allison AC
    Transplant Proc; 1991 Apr; 23(2 Suppl 2):19-25. PubMed ID: 2063417
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of mycophenolate mofetil in heart transplant recipients.
    Seebacher G; Mallinger R; Laufer G; Grimm M; Griesmacher A; Weigel G; Wolner E; Müller MM
    Adv Exp Med Biol; 1998; 431():801-3. PubMed ID: 9598174
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeuchi K; Takeyoshi I; Morishita Y; Kobayashi E
    Transplantation; 2004 Jun; 77(11):1661-7. PubMed ID: 15201664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of mycophenolate mofetil (RS61443): a short review.
    Bullingham RE; Nicholls A; Hale M
    Transplant Proc; 1996 Apr; 28(2):925-9. PubMed ID: 8623466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology.
    Gummert JF; Barten MJ; van Gelder T; Billingham ME; Morris RE
    Transplantation; 2000 Oct; 70(7):1038-49. PubMed ID: 11045640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts.
    Eggenhofer E; Steinmann JF; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
    Transpl Immunol; 2011 Apr; 24(3):157-63. PubMed ID: 21194567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil.
    Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
    Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor treatment with mycophenolate mofetil: protection against ischemia-reperfusion injury in the rat.
    Valentin JF; Bruijn JA; Paul LC
    Transplantation; 2000 Feb; 69(3):344-50. PubMed ID: 10706040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
    Fulton B; Markham A
    Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.